Perioperative efficiency and clinical outcomes of single-port versus multi-port robot-assisted radical prostatectomy: an updated meta-analysis
- Xi Xiao 1,2, Mengjie Wang 1, Yang Liu 1,2, Li Wang 1,2, Chengyu You 1,2, Peng Yu 1,2, Qixiang Fang 1,2, Kun Zhao 1,2, Zhongze Zhou 1,2, Yan Tao 3,4, Zhilong Dong 5,6
- Xi Xiao 1,2, Mengjie Wang 1, Yang Liu 1,2
- 1The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- 2Gansu Province Clinical Research Center for Urinary System Disease, Gansu, China.
- 3The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. taoy07@lzu.edu.cn.
- 4Gansu Province Clinical Research Center for Urinary System Disease, Gansu, China. taoy07@lzu.edu.cn.
- 5The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. dzl19780829@163.com.
- 6Gansu Province Clinical Research Center for Urinary System Disease, Gansu, China. dzl19780829@163.com.
- 0The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Single-port (SP) robot-assisted radical prostatectomy (RARP) shows reduced blood loss, shorter hospital stays, and less pain compared to multi-port (MP) RARP. Both SP-RARP and MP-RARP offer similar oncologic and functional outcomes for prostate cancer patients.
Area Of Science
- Urology
- Surgical Oncology
- Robotic Surgery
Background
- The comparative efficacy of single-port (SP) versus multi-port (MP) robot-assisted radical prostatectomy (RARP) for prostate cancer is not well-established.
- Conflicting evidence exists regarding perioperative outcomes, oncologic control, and functional recovery between SP-RARP and MP-RARP.
Purpose Of The Study
- To systematically review and compare perioperative outcomes, oncologic efficacy, and functional recovery between SP-RARP and MP-RARP.
- To synthesize current evidence on the relative benefits and drawbacks of each surgical approach for prostate cancer treatment.
Main Methods
- A systematic literature search was performed across major databases (PubMed, Embase, Web of Science, Cochrane Library) for English-language studies up to June 2025.
- Meta-analyses were conducted using R software (version 4.3.1), calculating weighted mean differences and odds ratios with 95% confidence intervals.
- The review protocol was prospectively registered with PROSPERO (CRD420251114408).
Main Results
- Patients undergoing SP-RARP demonstrated significantly lower estimated blood loss, shorter hospital stays, and earlier urinary catheter removal compared to MP-RARP.
- SP-RARP was associated with reduced postoperative pain scores and lower opioid consumption during hospitalization and at discharge.
- No significant differences were observed between SP-RARP and MP-RARP regarding functional outcomes (potency, continence), perioperative complications, positive surgical margins, biochemical recurrence, or operative duration.
Conclusions
- Single-port robot-assisted radical prostatectomy offers significant advantages in minimizing intraoperative blood loss, expediting patient recovery, and enhancing postoperative pain management compared to multi-port RARP.
- Despite a potentially longer operative time, both SP-RARP and MP-RARP yield comparable oncologic control and functional outcomes for prostate cancer patients.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

